APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epigenetics Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Epigenetics Services Market Outlook and Growth Opportunities 2026

6 March 2026195 pages

Choose your research edition.

Industry ResearchEpigenetics Services Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenetics Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Epigenetics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenetics Services Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Epigenetics Services Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Epigenetics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Epigenetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epigenetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epigenetics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Epigenetics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Epigenetics Services market include Bio-Rad, lllumina, QIAGEN, Thermo Fisher, Active Motif, Diagenode, Agilent, Merck Millipore and Abcam, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Epigenetics Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epigenetics Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epigenetics Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Epigenetics Services market.

Epigenetics Services Segment by Company

Bio-Rad

lllumina

QIAGEN

Thermo Fisher

Active Motif

Diagenode

Agilent

Merck Millipore

Abcam

New England Biolabs+

PerkinEImer

Zymo Research

Epigenetics Services Segment by Type

DNA Methylation

Histone Modification

Others

Epigenetics Services Segment by Application

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Contract Research Organization (CRO)

Epigenetics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Epigenetics Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Epigenetics Services key companies, revenue, market share, and recent developments.

3. To split the Epigenetics Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Epigenetics Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Epigenetics Services significant trends, drivers, influence factors in global and regions.

6. To analyze Epigenetics Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenetics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Epigenetics Services industry.

Chapter 3: Detailed analysis of Epigenetics Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Epigenetics Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Epigenetics Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Epigenetics Services Industry Trends Table 2. Epigenetics Services Industry Drivers Table 3. Epigenetics Services Industry Opportunities and Challenges Table 4. Epigenetics Services Industry Restraints Table 5. Global Epigenetics Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Epigenetics Services Revenue Share by Company (2021-2026) Table 7. Global Epigenetics Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Epigenetics Services Key Company Manufacturing Base & Headquarters Table 9. Global Epigenetics Services Company, Product Type & Application Table 10. Global Epigenetics Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Epigenetics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of DNA Methylation Table 15. Significant Companies of Histone Modification Table 16. Significant Companies of Others Table 17. Global Epigenetics Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Epigenetics Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Epigenetics Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Epigenetics Services Sales Value Share by Type (2021-2026) Table 21. Global Epigenetics Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Academic and Research Institutes Table 23. Significant Companies of Pharmaceutical and Biotechnology Companies Table 24. Significant Companies of Contract Research Organization (CRO) Table 25. Global Epigenetics Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Epigenetics Services Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Epigenetics Services Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Epigenetics Services Sales Value Share by Application (2021-2026) Table 29. Global Epigenetics Services Sales Value Share by Application (2027-2032) Table 30. Global Epigenetics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Epigenetics Services Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Epigenetics Services Sales Value Share by Region (2021-2026) Table 33. Global Epigenetics Services Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Epigenetics Services Sales Value Share by Region (2027-2032) Table 35. Global Epigenetics Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Epigenetics Services Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Epigenetics Services Sales Value Market Share by Country (2021-2026) Table 38. Global Epigenetics Services Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Epigenetics Services Sales Value Market Share by Country (2027-2032) Table 40. Bio-Rad Company Information Table 41. Bio-Rad Business Overview Table 42. Bio-Rad Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Bio-Rad Epigenetics Services Product Portfolio Table 44. Bio-Rad Recent Development Table 45. lllumina Company Information Table 46. lllumina Business Overview Table 47. lllumina Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. lllumina Epigenetics Services Product Portfolio Table 49. lllumina Recent Development Table 50. QIAGEN Company Information Table 51. QIAGEN Business Overview Table 52. QIAGEN Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. QIAGEN Epigenetics Services Product Portfolio Table 54. QIAGEN Recent Development Table 55. Thermo Fisher Company Information Table 56. Thermo Fisher Business Overview Table 57. Thermo Fisher Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Thermo Fisher Epigenetics Services Product Portfolio Table 59. Thermo Fisher Recent Development Table 60. Active Motif Company Information Table 61. Active Motif Business Overview Table 62. Active Motif Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Active Motif Epigenetics Services Product Portfolio Table 64. Active Motif Recent Development Table 65. Diagenode Company Information Table 66. Diagenode Business Overview Table 67. Diagenode Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Diagenode Epigenetics Services Product Portfolio Table 69. Diagenode Recent Development Table 70. Agilent Company Information Table 71. Agilent Business Overview Table 72. Agilent Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Agilent Epigenetics Services Product Portfolio Table 74. Agilent Recent Development Table 75. Merck Millipore Company Information Table 76. Merck Millipore Business Overview Table 77. Merck Millipore Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck Millipore Epigenetics Services Product Portfolio Table 79. Merck Millipore Recent Development Table 80. Abcam Company Information Table 81. Abcam Business Overview Table 82. Abcam Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Abcam Epigenetics Services Product Portfolio Table 84. Abcam Recent Development Table 85. New England Biolabs+ Company Information Table 86. New England Biolabs+ Business Overview Table 87. New England Biolabs+ Epigenetics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. New England Biolabs+ Epigenetics Services Product Portfolio Table 89. New England Biolabs+ Recent Development Table 90. PerkinEImer Company Information Table 91. PerkinEImer Business Overview Table 92. PerkinEImer Epigenetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. PerkinEImer Epigenetics Services Product Portfolio Table 94. PerkinEImer Recent Development Table 95. Zymo Research Company Information Table 96. Zymo Research Business Overview Table 97. Zymo Research Epigenetics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Zymo Research Epigenetics Services Product Portfolio Table 99. Zymo Research Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Epigenetics Services Product Image Figure 2. Global Epigenetics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epigenetics Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Epigenetics Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. DNA Methylation Image Figure 8. Histone Modification Image Figure 9. Others Image Figure 10. Global Epigenetics Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Epigenetics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Epigenetics Services Sales Value Share by Type (2021-2032) Figure 13. Academic and Research Institutes Image Figure 14. Pharmaceutical and Biotechnology Companies Image Figure 15. Contract Research Organization (CRO) Image Figure 16. Global Epigenetics Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Epigenetics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Epigenetics Services Sales Value Share by Application (2021-2032) Figure 19. Global Epigenetics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Epigenetics Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Epigenetics Services Sales Value (2021-2032) & (US$ Million) Figure 22. North America Epigenetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Epigenetics Services Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Epigenetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Epigenetics Services Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Epigenetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Epigenetics Services Sales Value (2021-2032) & (US$ Million) Figure 28. South America Epigenetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Epigenetics Services Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Epigenetics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Epigenetics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Epigenetics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Epigenetics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation
  • Histone Modification
  • Others
Applications
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organization (CRO)
Companies covered
  • Bio-Rad
  • lllumina
  • QIAGEN
  • Thermo Fisher
  • Active Motif
  • Diagenode
  • Agilent
  • Merck Millipore
  • Abcam
  • New England Biolabs+
  • PerkinEImer
  • Zymo Research

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Epigenetics Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Epigenetics Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Epigenetics Services Market Dynamics
  1. 2.1 Epigenetics Services Industry Trends
  2. 2.2 Epigenetics Services Industry Drivers
  3. 2.3 Epigenetics Services Industry Opportunities and Challenges
  4. 2.4 Epigenetics Services Industry Restraints
3 Epigenetics Services Market by Company
  1. 3.1 Global Epigenetics Services Company Revenue Ranking in 2025
  2. 3.2 Global Epigenetics Services Revenue by Company (2021-2026)
  3. 3.3 Global Epigenetics Services Company Ranking (2024-2026)
  4. 3.4 Global Epigenetics Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Epigenetics Services Company Product Type and Application
  6. 3.6 Global Epigenetics Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Epigenetics Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Epigenetics Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Epigenetics Services Market by Type
  1. 4.1 Epigenetics Services Type Introduction
  2. 4.1.1 DNA Methylation
  3. 4.1.2 Histone Modification
  4. 4.1.3 Others
  5. 4.2 Global Epigenetics Services Sales Value by Type
  6. 4.2.1 Global Epigenetics Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Epigenetics Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Epigenetics Services Sales Value Share by Type (2021-2032)
5 Epigenetics Services Market by Application
  1. 5.1 Epigenetics Services Application Introduction
  2. 5.1.1 Academic and Research Institutes
  3. 5.1.2 Pharmaceutical and Biotechnology Companies
  4. 5.1.3 Contract Research Organization (CRO)
  5. 5.2 Global Epigenetics Services Sales Value by Application
  6. 5.2.1 Global Epigenetics Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Epigenetics Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Epigenetics Services Sales Value Share by Application (2021-2032)
6 Epigenetics Services Regional Value Analysis
  1. 6.1 Global Epigenetics Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Epigenetics Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Epigenetics Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Epigenetics Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Epigenetics Services Sales Value (2021-2032)
  7. 6.3.2 North America Epigenetics Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Epigenetics Services Sales Value (2021-2032)
  10. 6.4.2 Europe Epigenetics Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Epigenetics Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Epigenetics Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Epigenetics Services Sales Value (2021-2032)
  16. 6.6.2 South America Epigenetics Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Epigenetics Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Epigenetics Services Sales Value Share by Country, 2025 VS 2032
7 Epigenetics Services Country-level Value Analysis
  1. 7.1 Global Epigenetics Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Epigenetics Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Epigenetics Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Epigenetics Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Epigenetics Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Epigenetics Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Epigenetics Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Epigenetics Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Epigenetics Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Epigenetics Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Epigenetics Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Epigenetics Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Epigenetics Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Epigenetics Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Epigenetics Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Epigenetics Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Epigenetics Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Epigenetics Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Epigenetics Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Epigenetics Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Epigenetics Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Epigenetics Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Epigenetics Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Epigenetics Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Epigenetics Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Epigenetics Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Epigenetics Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Epigenetics Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Epigenetics Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Epigenetics Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Epigenetics Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Epigenetics Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Epigenetics Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Epigenetics Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Epigenetics Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bio-Rad
  2. 8.1.1 Bio-Rad Company Information
  3. 8.1.2 Bio-Rad Business Overview
  4. 8.1.3 Bio-Rad Epigenetics Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bio-Rad Epigenetics Services Product Portfolio
  6. 8.1.5 Bio-Rad Recent Developments
  7. 8.2 lllumina
  8. 8.2.1 lllumina Company Information
  9. 8.2.2 lllumina Business Overview
  10. 8.2.3 lllumina Epigenetics Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 lllumina Epigenetics Services Product Portfolio
  12. 8.2.5 lllumina Recent Developments
  13. 8.3 QIAGEN
  14. 8.3.1 QIAGEN Company Information
  15. 8.3.2 QIAGEN Business Overview
  16. 8.3.3 QIAGEN Epigenetics Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 QIAGEN Epigenetics Services Product Portfolio
  18. 8.3.5 QIAGEN Recent Developments
  19. 8.4 Thermo Fisher
  20. 8.4.1 Thermo Fisher Company Information
  21. 8.4.2 Thermo Fisher Business Overview
  22. 8.4.3 Thermo Fisher Epigenetics Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Epigenetics Services Product Portfolio
  24. 8.4.5 Thermo Fisher Recent Developments
  25. 8.5 Active Motif
  26. 8.5.1 Active Motif Company Information
  27. 8.5.2 Active Motif Business Overview
  28. 8.5.3 Active Motif Epigenetics Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Active Motif Epigenetics Services Product Portfolio
  30. 8.5.5 Active Motif Recent Developments
  31. 8.6 Diagenode
  32. 8.6.1 Diagenode Company Information
  33. 8.6.2 Diagenode Business Overview
  34. 8.6.3 Diagenode Epigenetics Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Diagenode Epigenetics Services Product Portfolio
  36. 8.6.5 Diagenode Recent Developments
  37. 8.7 Agilent
  38. 8.7.1 Agilent Company Information
  39. 8.7.2 Agilent Business Overview
  40. 8.7.3 Agilent Epigenetics Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Agilent Epigenetics Services Product Portfolio
  42. 8.7.5 Agilent Recent Developments
  43. 8.8 Merck Millipore
  44. 8.8.1 Merck Millipore Company Information
  45. 8.8.2 Merck Millipore Business Overview
  46. 8.8.3 Merck Millipore Epigenetics Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck Millipore Epigenetics Services Product Portfolio
  48. 8.8.5 Merck Millipore Recent Developments
  49. 8.9 Abcam
  50. 8.9.1 Abcam Company Information
  51. 8.9.2 Abcam Business Overview
  52. 8.9.3 Abcam Epigenetics Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Abcam Epigenetics Services Product Portfolio
  54. 8.9.5 Abcam Recent Developments
  55. 8.10 New England Biolabs+
  56. 8.10.1 New England Biolabs+ Company Information
  57. 8.10.2 New England Biolabs+ Business Overview
  58. 8.10.3 New England Biolabs+ Epigenetics Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 New England Biolabs+ Epigenetics Services Product Portfolio
  60. 8.10.5 New England Biolabs+ Recent Developments
  61. 8.11 PerkinEImer
  62. 8.11.1 PerkinEImer Company Information
  63. 8.11.2 PerkinEImer Business Overview
  64. 8.11.3 PerkinEImer Epigenetics Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PerkinEImer Epigenetics Services Product Portfolio
  66. 8.11.5 PerkinEImer Recent Developments
  67. 8.12 Zymo Research
  68. 8.12.1 Zymo Research Company Information
  69. 8.12.2 Zymo Research Business Overview
  70. 8.12.3 Zymo Research Epigenetics Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zymo Research Epigenetics Services Product Portfolio
  72. 8.12.5 Zymo Research Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst